{
  "source": "twitter",
  "source_id": "003",
  "url": "https://twitter.com/metabolic_research/status/003",
  "permalink": null,
  "title": null,
  "text": "Our latest study on post-bariatric hypoglycemia published in JAMA. 127 patients post-RYGB evaluated for PBH symptoms. 34% presented with severe hypoglycemic episodes <50mg/dL. Acarbose showed 67% efficacy in symptom reduction. Novel GLP-1 antagonist therapies showing promise. Link to full paper: [redacted] #BariatricResearch #Endocrinology",
  "parent_source": null,
  "subsource": null,
  "author": {
    "id": "twitter_user_003",
    "name": "User c",
    "handle": "user_c",
    "gender": "male",
    "age": 45,
    "subscribers": 12500
  },
  "country": "US",
  "published_at": "2025-05-12T09:15:00+00:00",
  "language": "eng",
  "metrics": {
    "likes": 234,
    "comments": 45,
    "shares": 89
  },
  "topics": [
    "bariatric_surgery"
  ],
  "symptoms": [
    "hypoglycemia"
  ],
  "treatments": [
    "acarbose"
  ],
  "conditions": [
    "PBH"
  ],
  "companies": [],
  "engagement_score": 591,
  "engagement_label": "high",
  "key_phrases": [
    "post-bariatric hypoglycemia",
    "roux-en-y gastric bypass",
    "pbh symptoms",
    "severe hypoglycemic episodes",
    "acarbose efficacy",
    "symptom reduction",
    "glp-1 antagonist",
    "research study"
  ],
  "bariatric_context": "strong",
  "relevance_label": "relevant",
  "relevance_confidence": 0.95,
  "relevance_reason": "PBH explicitly mentioned in clinical research context",
  "audience_label": "hcp",
  "audience_confidence": 0.9,
  "themes": [
    "Symptoms",
    "Treatments",
    "Conditions/Diagnosis",
    "Bariatric Surgery"
  ],
  "sentiment_label": "neutral",
  "sentiment_confidence": 0.9,
  "sentiment_raw": "neutral",
  "emotions": [],
  "intent": [
    "news"
  ],
  "flags": [],
  "debug_matches": [
    "conditions_PBH_008",
    "topics_bariatric_surgery_034",
    "symptoms_hypoglycemia_016",
    "treatments_acarbose_025"
  ]
}